AU2001289659A1 - Tocotrienolquinone cyclisation product with an anti-hypercholesterol effect - Google Patents
Tocotrienolquinone cyclisation product with an anti-hypercholesterol effectInfo
- Publication number
- AU2001289659A1 AU2001289659A1 AU2001289659A AU8965901A AU2001289659A1 AU 2001289659 A1 AU2001289659 A1 AU 2001289659A1 AU 2001289659 A AU2001289659 A AU 2001289659A AU 8965901 A AU8965901 A AU 8965901A AU 2001289659 A1 AU2001289659 A1 AU 2001289659A1
- Authority
- AU
- Australia
- Prior art keywords
- tocotrienolquinone
- hypercholesterol
- effect
- sup
- cyclisation product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Mycology (AREA)
- Heart & Thoracic Surgery (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10034233A DE10034233A1 (de) | 2000-07-14 | 2000-07-14 | Tocotrienolchinon-Cyclisierungsprodukte |
DE10034233 | 2000-07-14 | ||
PCT/EP2001/008163 WO2002006261A1 (de) | 2000-07-14 | 2001-07-13 | Tocotrienolchinon-zyklisierungsprodukte mit antihypercholesterin wirkung |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001289659A1 true AU2001289659A1 (en) | 2002-01-30 |
Family
ID=7648895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001289659A Abandoned AU2001289659A1 (en) | 2000-07-14 | 2001-07-13 | Tocotrienolquinone cyclisation product with an anti-hypercholesterol effect |
Country Status (10)
Country | Link |
---|---|
US (1) | US6977270B2 (da) |
EP (1) | EP1301501B1 (da) |
JP (1) | JP2004504313A (da) |
CN (1) | CN1441793A (da) |
AT (1) | ATE263160T1 (da) |
AU (1) | AU2001289659A1 (da) |
DE (2) | DE10034233A1 (da) |
DK (1) | DK1301501T3 (da) |
ES (1) | ES2218448T3 (da) |
WO (1) | WO2002006261A1 (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120046237A1 (en) * | 1998-04-08 | 2012-02-23 | Theoharides Theoharis C | Compositions for protection against superficial vasodilator flush syndrome, and methods of use |
EP2471530B1 (en) | 2005-06-01 | 2017-01-11 | Edison Pharmaceuticals, Inc. | Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
PT1933821T (pt) * | 2005-09-15 | 2020-10-15 | Ptc Therapeutics Inc | Variantes de cauda de terapêuticos redox-ativos para tratamento de doenças mitocondriais e outras condições e modulação de biomarcadores energéticos |
CA2635280C (en) | 2006-02-22 | 2017-12-12 | Edison Pharmaceuticals, Inc. | Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
WO2010030607A1 (en) | 2008-09-10 | 2010-03-18 | Edison Pharmaceuticals, Inc. | Treatment of pervasive developmental disorders with redox-active therapeutics |
SI2963006T1 (sl) * | 2008-10-28 | 2019-01-31 | Bioelectron Technology Corporation | Sestavek vsebujoč alfa-tokotrienol kinon in njegove vmesne povezave |
DK2424495T3 (da) | 2009-04-28 | 2018-04-30 | Bioelectron Tech Corp | Behandling af lebers arvelig optisk neuropati og dominant optisk atrofi med tocotrienol-quinoner |
CN102647981B (zh) * | 2009-08-26 | 2016-09-28 | 爱迪生制药有限公司 | 预防和治疗脑缺血的方法 |
JP2014520894A (ja) | 2011-07-19 | 2014-08-25 | エジソン ファーマシューティカルズ, インコーポレイテッド | 非アルファトコトリエノールの存在下でのアルファトコトリエノールの選択的酸化のための方法 |
US10251861B2 (en) | 2012-06-08 | 2019-04-09 | Ohio State Innovation Foundation | Methods for treating burn and scar injury using tocotrienol compositions |
WO2017106786A1 (en) | 2015-12-16 | 2017-06-22 | Bioelectron Technology Corporation | Improved methods for enriching alpha-tocotrienol from mixed tocol compositions |
WO2017106803A1 (en) | 2015-12-17 | 2017-06-22 | Bioelectron Technology Corporation | Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR910007523A (ko) * | 1989-10-04 | 1991-05-30 | 브리스톨-마이어즈 스퀴브 컴페니 | 과콜레스테린혈증, 과지방혈증 및 혈전색전증 질병 치료용 토코트리엔올 |
US5217992A (en) * | 1989-10-04 | 1993-06-08 | Bristol-Myers Squibb Company | Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders |
CA2050514A1 (en) | 1990-09-14 | 1992-03-15 | Bradley C. Pearce | Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia |
CA2096496A1 (en) | 1992-05-29 | 1993-11-30 | Bradley C. Pearce | Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia |
US5318993A (en) * | 1993-04-16 | 1994-06-07 | Bristol-Myers Squibb Company | Antihyperlipidemic benzoquinones |
EP0669132A1 (en) * | 1994-02-23 | 1995-08-30 | van der Kraaij, Antonius Marinus Maria | Pharmaceutical composition of vitamin E and acetylsalicylate for treatment and prevention of atherosclerosis |
JP3926888B2 (ja) | 1997-05-27 | 2007-06-06 | 株式会社カネカ | コレステロール低下剤 |
-
2000
- 2000-07-14 DE DE10034233A patent/DE10034233A1/de not_active Withdrawn
-
2001
- 2001-07-13 ES ES01969391T patent/ES2218448T3/es not_active Expired - Lifetime
- 2001-07-13 US US10/332,863 patent/US6977270B2/en not_active Expired - Lifetime
- 2001-07-13 WO PCT/EP2001/008163 patent/WO2002006261A1/de active IP Right Grant
- 2001-07-13 DE DE50101861T patent/DE50101861D1/de not_active Expired - Fee Related
- 2001-07-13 CN CN01812696A patent/CN1441793A/zh active Pending
- 2001-07-13 EP EP01969391A patent/EP1301501B1/de not_active Expired - Lifetime
- 2001-07-13 DK DK01969391T patent/DK1301501T3/da active
- 2001-07-13 JP JP2002512165A patent/JP2004504313A/ja not_active Withdrawn
- 2001-07-13 AT AT01969391T patent/ATE263160T1/de not_active IP Right Cessation
- 2001-07-13 AU AU2001289659A patent/AU2001289659A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1301501A1 (de) | 2003-04-16 |
WO2002006261A1 (de) | 2002-01-24 |
DE50101861D1 (de) | 2004-05-06 |
CN1441793A (zh) | 2003-09-10 |
ATE263160T1 (de) | 2004-04-15 |
ES2218448T3 (es) | 2004-11-16 |
DE10034233A1 (de) | 2002-01-24 |
US20040116715A1 (en) | 2004-06-17 |
US6977270B2 (en) | 2005-12-20 |
JP2004504313A (ja) | 2004-02-12 |
DK1301501T3 (da) | 2004-07-19 |
EP1301501B1 (de) | 2004-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6613896A (en) | Chemical compounds | |
EP1193270A3 (en) | Pyrrolobenzodiazepines | |
AU5485698A (en) | Oxyiminopregnancarbolactone | |
AU7278500A (en) | Fungicides | |
AU2002246728A1 (en) | Carboline derivatives | |
AU2674301A (en) | Liquid crystalline medium | |
AU2001266575A1 (en) | Chemical compounds | |
AU2002249890A1 (en) | Carboline derivatives | |
WO2001055066A3 (en) | 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicides | |
IT1285770B1 (it) | Composti corticoidei | |
AU2001289659A1 (en) | Tocotrienolquinone cyclisation product with an anti-hypercholesterol effect | |
NO20002676D0 (no) | Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme | |
AU1044500A (en) | Imidazonaphthyridines | |
AU7520898A (en) | Tetrahydropyrido compounds | |
AU2001293707A1 (en) | Anti-inflammatory medicament | |
AU2002213419A1 (en) | Condensed pyridoindole derivatives | |
AU7027100A (en) | Novel compounds | |
AU2001263278A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
AU6339000A (en) | Serotonergic benzothiophenes | |
WO2001009122A3 (en) | Serotonergic benzofurans | |
AU5539899A (en) | Novel triazolo(4,5-(d))pyrimidine compounds | |
AU2881399A (en) | N1-modified glycopeptides | |
AU5390900A (en) | Potassium channel blocking agents | |
AU1303099A (en) | Herbicidal furanyl- and thienyloxyazines | |
AU2001261707A1 (en) | Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives |